Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors-Reference-Cited by-同舟云学术

Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors

Published:2016-02-09 Issue:11 Volume:46 Page:1282-1289
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Masui Toshihiko,Doi Ryuichiro,Kawaguchi Yoshiya,Sato Asahi,Nakano Kenzo,Ito Tatsuo,Anazawa Takayuki,Takaori Kyoichi,Uemoto Shinji

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00595-016-1310-z.pdf

Reference31 articles.

1. Ando M, Shimizu Y, Sano T, Senda Y, Nimura Y, Yamao K, et al. Poor prognosis of common-type invasive ductal carcinomas that originate in the branching pancreatic duct. Surg Today. 2015;45(10):1291–8.

2. Nimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y, et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepato-Biliary-Pancreat Sci. 2012;19(3):230–41.

3. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4(6):567–79 (PubMed PMID: 11307091).

4. Christein JD, Kendrick ML, Iqbal CW, Nagorney DM, Farnell MB. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas. J Gastrointest Surg. 2005;9(7):922–7 (PubMed PMID: 16137585).

5. Bilimoria KY, Talamonti MS, Sener SF, Bilimoria MM, Stewart AK, Winchester DP, et al. Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg. 2008;207(4):510–9.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to Upfront Resection Approach for Borderline Resectable Pancreatic Adenocarcinoma;The American Surgeon™;2024-04-18

2. Comparison of the upfront surgery and neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: an updated systematic review and meta-analysis;Updates in Surgery;2023-08-28

3. Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis;Cancers;2022-09-07

4. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?;Frontiers in Oncology;2022-06-16

5. Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution;BMC Cancer;2022-01-29